Easton Pharmaceuticals Inc. (EAPH)

Overview

Parallel Industries Inc., formerly known as Easton Pharmaceuticals Inc., is a company that has shifted its focus away from significant operations. Established in 1997 and headquartered in Toronto, Canada, it was previously engaged in the development and marketing of topically delivered drugs aimed at treating cancer, along with other therapeutic products designed to address various conditions. In December 2020, the company underwent a name change to Parallel Industries Inc., marking a pivot in its strategic direction. Despite its rich history in pharmaceutical development, the company now reports that it does not have significant operations, which indicates a period of transition or redirection away from its earlier activities in drug development and marketing.

Products and Services

Before its phase of currently having no significant operations, Parallel Industries Inc. was involved in several key areas of pharmaceuticals, including:

• Topically Delivered Drugs: The primary focus was on developing drugs that could be applied topically to treat cancer. This innovative approach aimed to offer alternative treatment methods to traditional oral or intravenous therapies, potentially reducing side effects and improving patient compliance.
• Therapeutic Products: Beyond cancer treatment, the company also engaged in the development of products meant to treat various conditions. These therapeutic products were designed to address a range of health issues, providing potential solutions to unmet medical needs.
• Prescription and Over-the-Counter Products: Parallel Industries Inc. aimed to produce and market a mix of prescription and over-the-counter offerings. This broad approach intended to cater to both specific medical prescriptions and general consumer health needs, comprising a diverse portfolio of pharmaceutical products.